Pricing
Login
Home
Charts
Search
Watchlist
Products

Lyka Labs Ltd

LYKALABS
₹93.41+2.00%20 Nov 2026
Reports
Pharma Formulations

Lyka Labs Ltd

LYKALABS
₹93.41
+2.00%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹338Cr
Close
Close Price
₹93.41
Industry
Industry
Pharma Formulations
PE
Price To Earnings
—
PS
Price To Sales
2.32
Revenue
Revenue
₹145Cr
Rev Gr TTM
Revenue Growth TTM
6.10%
PAT Gr TTM
PAT Growth TTM
-294.44%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
332830413433333731284244
Growth YoY
Revenue Growth YoY%
82.724.931.647.03.820.49.7-10.9-9.1-16.128.120.6
Expenses
ExpensesCr
262626362929293929343841
Operating Profit
Operating ProfitCr
7245544-32-654
OPM
OPM%
21.17.312.312.015.412.211.2-6.95.4-23.110.88.0
Other Income
Other IncomeCr
101011111101
Interest Expense
Interest ExpenseCr
111110111111
Depreciation
DepreciationCr
332221222222
PBT
PBTCr
3-223431-40-921
Tax
TaxCr
1011110-10-100
PAT
PATCr
2-212321-30-821
Growth YoY
PAT Growth YoY%
117.130.6169.7489.851.7197.1-22.5-268.1-105.6-497.5105.0139.6
NPM
NPM%
5.5-7.54.34.68.06.13.0-8.8-0.5-28.84.82.9
EPS
EPS₹
0.5-3.80.40.60.80.50.3-0.90.0-2.10.60.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
332830413433333731284244
Growth YoY
Revenue Growth YoY%
82.724.931.647.03.820.49.7-10.9-9.1-16.128.120.6
Expenses
ExpensesCr
262626362929293929343841
Operating Profit
Operating ProfitCr
7245544-32-654
OPM
OPM%
21.17.312.312.015.412.211.2-6.95.4-23.110.88.0
Other Income
Other IncomeCr
101011111101
Interest Expense
Interest ExpenseCr
111110111111
Depreciation
DepreciationCr
332221222222
PBT
PBTCr
3-223431-40-921
Tax
TaxCr
1011110-10-100
PAT
PATCr
2-212321-30-821
Growth YoY
PAT Growth YoY%
117.130.6169.7489.851.7197.1-22.5-268.1-105.6-497.5105.0139.6
NPM
NPM%
5.5-7.54.34.68.06.13.0-8.8-0.5-28.84.82.9
EPS
EPS₹
0.5-3.80.40.60.80.50.3-0.90.0-2.10.60.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1301106071618619493111139128145
Growth
Revenue Growth%
-15.6-45.718.4-13.140.3125.0-52.019.524.6-7.36.1
Expenses
ExpensesCr
1108763736567937695121132142
Operating Profit
Operating ProfitCr
2123-4-2-420101171618-33
OPM
OPM%
15.720.7-5.9-2.7-6.022.852.118.114.112.9-2.72.2
Other Income
Other IncomeCr
9-241-300-4-41243
Interest Expense
Interest ExpenseCr
1519107202620125234
Depreciation
DepreciationCr
91011788171413788
PBT
PBTCr
4-8-20-15-62-1459-13-111-12-6
Tax
TaxCr
0-2-1-91-421023-1-1
PAT
PATCr
4-7-19-6-63-1038-13-38-10-5
Growth
PAT Growth%
-261.3-188.166.6-885.983.9481.0-134.280.1402.7-231.5-294.4
NPM
NPM%
3.1-6.0-31.8-9.0-101.8-11.719.8-14.1-2.45.7-8.1-3.4
EPS
EPS₹
1.6-2.6-6.7-1.8-21.3-4.113.6-4.6-0.82.2-2.8-1.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1301106071618619493111139128145
Growth
Revenue Growth%
-15.6-45.718.4-13.140.3125.0-52.019.524.6-7.36.1
Expenses
ExpensesCr
1108763736567937695121132142
Operating Profit
Operating ProfitCr
2123-4-2-420101171618-33
OPM
OPM%
15.720.7-5.9-2.7-6.022.852.118.114.112.9-2.72.2
Other Income
Other IncomeCr
9-241-300-4-41243
Interest Expense
Interest ExpenseCr
1519107202620125234
Depreciation
DepreciationCr
91011788171413788
PBT
PBTCr
4-8-20-15-62-1459-13-111-12-6
Tax
TaxCr
0-2-1-91-421023-1-1
PAT
PATCr
4-7-19-6-63-1038-13-38-10-5
Growth
PAT Growth%
-261.3-188.166.6-885.983.9481.0-134.280.1402.7-231.5-294.4
NPM
NPM%
3.1-6.0-31.8-9.0-101.8-11.719.8-14.1-2.45.7-8.1-3.4
EPS
EPS₹
1.6-2.6-6.7-1.8-21.3-4.113.6-4.6-0.82.2-2.8-1.2
Sales CAGR
1 Year-7%
3 Years11%
5 Years8%
TTM6%
EBITDA CAGR
1 Year-
3 Years-
5 Years-
TTM-69%
Avg. ROCE
1 Year-6%
3 Years2%
5 Years12%
TTM-2%
CFO / EBITDA
1 Year-
3 Years30%
5 Years66%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
222228282929293133363636
Reserves
ReservesCr
22162114-43-54-15-326695760
Current Liabilities
Current LiabilitiesCr
163165167856650993338475461
Non Current Liabilities
Non Current LiabilitiesCr
3042985149165737351263028
Total Liabilities
Total LiabilitiesCr
242252229216200190186152157176175182
Current Assets
Current AssetsCr
826349353629524451676370
Non Current Assets
Non Current AssetsCr
160189180181164161133107106109111112
Total Assets
Total AssetsCr
242252229216200190186152157176175182
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
222228282929293133363636
Reserves
ReservesCr
22162114-43-54-15-326695760
Current Liabilities
Current LiabilitiesCr
163165167856650993338475461
Non Current Liabilities
Non Current LiabilitiesCr
3042985149165737351263028
Total Liabilities
Total LiabilitiesCr
242252229216200190186152157176175182
Current Assets
Current AssetsCr
826349353629524451676370
Non Current Assets
Non Current AssetsCr
160189180181164161133107106109111112
Total Assets
Total AssetsCr
242252229216200190186152157176175182

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1231112759799225
Investing Cash Flow
Investing Cash FlowCr
17-13-3-400-67-9-12-9
Financing Cash Flow
Financing Cash FlowCr
-30-19-10-233-12-63-22254
Net Cash Flow
Net Cash FlowCr
-10-3-19-310-5-6-50
Free Cash Flow
Free Cash FlowCr
2818723487215-7-10-6
CFO To PAT
CFO To PAT%
292.1-475.7-57.3-419.8-8.5-87.3206.1-68.1-67.723.9-50.2
CFO To EBITDA
CFO To EBITDA%
58.3137.8-306.5-1,404.0-145.144.878.353.211.310.6-150.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1231112759799225
Investing Cash Flow
Investing Cash FlowCr
17-13-3-400-67-9-12-9
Financing Cash Flow
Financing Cash FlowCr
-30-19-10-233-12-63-22254
Net Cash Flow
Net Cash FlowCr
-10-3-19-310-5-6-50
Free Cash Flow
Free Cash FlowCr
2818723487215-7-10-6
CFO To PAT
CFO To PAT%
292.1-475.7-57.3-419.8-8.5-87.3206.1-68.1-67.723.9-50.2
CFO To EBITDA
CFO To EBITDA%
58.3137.8-306.5-1,404.0-145.144.878.353.211.310.6-150.4

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
173120129693775389321351360160338
Price To Earnings
Price To Earnings
35.310.045.1
Price To Sales
Price To Sales
1.31.12.21.00.60.92.03.53.12.61.22.3
Price To Book
Price To Book
4.63.52.71.6-2.5-2.929.211.55.93.41.73.5
EV To EBITDA
EV To EBITDA
12.38.8-50.0-85.7-45.511.75.022.825.722.2-59.4116.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.048.346.039.835.349.869.552.753.853.353.853.8
OPM
OPM%
15.720.7-5.9-2.7-6.022.852.118.114.112.9-2.72.2
NPM
NPM%
3.1-6.0-31.8-9.0-101.8-11.719.8-14.1-2.45.7-8.1-3.4
ROCE
ROCE%
14.88.6-10.5-6.0-33.18.655.4-1.33.49.3-6.0-1.6
ROE
ROE%
9.3-17.5-39.0-15.0436.539.1288.2-47.0-4.47.6-11.3-5.1
ROA
ROA%
1.7-2.6-8.3-2.9-31.3-5.320.7-8.7-1.74.5-6.0-2.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
173120129693775389321351360160338
Price To Earnings
Price To Earnings
35.310.045.1
Price To Sales
Price To Sales
1.31.12.21.00.60.92.03.53.12.61.22.3
Price To Book
Price To Book
4.63.52.71.6-2.5-2.929.211.55.93.41.73.5
EV To EBITDA
EV To EBITDA
12.38.8-50.0-85.7-45.511.75.022.825.722.2-59.4116.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.048.346.039.835.349.869.552.753.853.353.853.8
OPM
OPM%
15.720.7-5.9-2.7-6.022.852.118.114.112.9-2.72.2
NPM
NPM%
3.1-6.0-31.8-9.0-101.8-11.719.8-14.1-2.45.7-8.1-3.4
ROCE
ROCE%
14.88.6-10.5-6.0-33.18.655.4-1.33.49.3-6.0-1.6
ROE
ROE%
9.3-17.5-39.0-15.0436.539.1288.2-47.0-4.47.6-11.3-5.1
ROA
ROA%
1.7-2.6-8.3-2.9-31.3-5.320.7-8.7-1.74.5-6.0-2.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr486435402338243237233
Close PriceClose₹406.05762.60285.9093.41680.10150.0038.16
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE20.8915.1432.1611.1112.40
Price To SalesPS3.111.151.912.322.131.065.75
RevenueRevenueCr15637821014511422441
Revenue Growth TTMRev Gr TTM%55.2%19.7%27.5%6.1%28.2%26.7%-8.4%
PAT Growth TTMPAT Gr TTM%39.5%290.6%41.9%-294.4%26.1%43.3%-238.4%
Market CapitalizationMkt CapCr486435402338243237233
Close PriceClose₹406.05762.60285.9093.41680.10150.0038.16
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE20.8915.1432.1611.1112.40
Price To SalesPS3.111.151.912.322.131.065.75
RevenueRevenueCr15637821014511422441
Revenue Growth TTMRev Gr TTM%55.2%19.7%27.5%6.1%28.2%26.7%-8.4%
PAT Growth TTMPAT Gr TTM%39.5%290.6%41.9%-294.4%26.1%43.3%-238.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews